Elad Gil’s Latest AI Bet Is in Health

The boom in artificial intelligence funding has extended into the healthcare sector, where startups are developing generative AI tools to improve patient care.

Abridge, a six-year-old startup that uses AI to transcribe doctors’ conversations with their patients, is raising $250 million at a valuation of $2.5 billion before the investment, according to people familiar with the deal. Elad Gil, a prolific solo fund manager and a co-founder of Color Genomics (now Color Health), is co-leading the round alongside IVP. Alphabet’s growth investing arm CapitalG is also participating in the round, one of the people said.